🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Vildagliptin is an oral anti-diabetic agent. This is a 24-week study to ass...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-05
Trial ID
NCT00351884
Treatments Being Tested
This study is designed to evaluate, in a primary care setting, the safety a...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2006-10
Trial ID
NCT00396227
Treatments Being Tested
This study will investigate efficacy and safety of vildagliptin in patients...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-06
Trial ID
NCT00494884
Treatments Being Tested
This is a 2-3 period parallel group study with an adaptive element in Type ...
Status
Completed
Location
Instituto de Investigaciones Biomedicas
Start Date
2009-02
Trial ID
NCT00860288
Treatments Being Tested
The study will assess glycemic variability and optimized glycemic control i...
Status
Completed
Location
Investigative Site
Start Date
2010-06
Trial ID
NCT01193296
Treatments Being Tested
To assess the efficacy and safety of vildagliptin add-on therapy to reduce ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01224366
Treatments Being Tested
The randomized, controlled clinical trial investigate the efficacy and safe...
Status
Unknown
Location
The first afilliated hospital of Xiamen university
Start Date
2018-06-10
Trial ID
NCT03563794
Treatments Being Tested
The purpose of the study is to assess if the addition of vildagliptin as ad...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-05
Trial ID
NCT01862263
Treatments Being Tested
The purpose of this study is to improve blood glucose control in Type 2 Dia...
Status
Completed
Location
Post Graduate Institute of Medical Education and Research
Start Date
2009-11
Trial ID
NCT01065298
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of vildagli...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01497522
Treatments Being Tested